FREE CONSULTATION (713) 621-7944


M.D. Anderson Cancer Center

September 25, 2011 · FLEMING | NOLEN | JEZ, L.L.P.

The University of Texas M.D. Anderson Cancer Center was founded in 1941 by the Texas Legislature and is a world leader in the effort to conquer cancer. Their designation as one of the National Cancer Institute’s 40 Comprehensive Cancer Centers attests to the breadth and depth of their expertise in cancer patient care, research, education and prevention.


To eliminate cancer in Texas, the nation and the world through outstanding programs that integrate patient care, research and prevention, and through educationfor undergraduate and graduate students, trainees, professionals, employees and the public.

People Served

Almost 700,000 patients have registered since 1944. In 2007, M.D. Anderson treated 84,969 patients; 29,157 or whom were new patients.

Facilities and Staff

512-bed hospital, outpatient clinic, clinical and basic research facilities and a biotech research park. Approximately 1,312 full-time faculty and more than 15,000 employees.


  • For five of the last eight years, M.D. Anderson Cancer Center has ranked No. 1 in cancer care in ” America’s Best Hospitals“, a survey published annually inU.S. News & World Report.
  • M.D. Anderson holds accreditation from the Joint Commission
  • M.D. Anderson has the Magnet Nursing Services Recognition, the highest honor in healt care for nursing services.
  • Approximately 10,000 patients participate in M.D. Anderson clinical trials to test new therapies – more than any other cancer center. This helps them move advances from the laboratory to the clinic to benefit patients faster than most other institutions.
  • M.D. Anderson grants B.S. degrees in the health sciences and shares degree-granting status with The University of Texas Health Science Center at Houston for M.S. and Ph.D. degrees in the Graduate School of Biomedical Sciences.


  • Enhance the excellence, value, safety and efficiency of our patient care.
  • Enhance the quality of existing research programs and develop priority programs for the future.
  • Expand research addressing risk assessment, prevention and early detection of cancer and develop strategies to disseminate these finding.
  • Enhance the quality and outcomes of their undergraduate and graduate degree-granting programs, and their post-doctoral training programs.